The global artificial ventilation and anesthesia masks market size is anticipated to reach USD 3.30 billion by 2030. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.
Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.
According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.
The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.
The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.
This product will be delivered within 1-3 business days.
Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.
According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.
The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.
The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.
Artificial Ventilation And Anesthesia Masks Market Report Highlights
- Disposable masks accounted for the largest revenue share of 68.0% in 2023. The dominance of disposable masks in the medical industry is driven by their cost-effectiveness, user convenience, reduced infection risk, and adherence to legal requirements.
- The operating rooms application segment dominated the market with a revenue share of 32.0% in 2023. Operating rooms have modern working ventilation systems and devices for anesthesia where one is able to control in detail the amount of air circulation and the concentration of the anesthetic mixture.
- Reusable masks are expected to grow significantly over the forecast period, registering a CAGR of 4.6%. Reusable masks offer a cost-effective solution for hospitals, as they can be cleaned and reused, reducing waste and minimizing costs.
- North America artificial ventilation and anesthesia masks market dominated the global artificial ventilation and anesthesia masks market with a revenue share of 36.1% in 2023.
The leading players in the Artificial Ventilation and Anesthesia Masks market include:
- GaleMed Corporation.
- Drägerwerk AG & Co. KGaA
- BD
- Air Liquide Medical Systems
- Koninklijke Philips N.V.
- ResMed
- Ambu A/S
- VYAIRE MEDICAL, INC.
- NIHON KOHDEN CORPORATION
- Hamilton Medical
- Thermo Fisher Scientific Inc.
- Medtronic
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Artificial Ventilation and Anesthesia Masks Market Variables, Trends, & Scope
Chapter 4. Artificial Ventilation and Anesthesia Masks Market: Masks Estimates & Trend Analysis
Chapter 5. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis
Chapter 6. Artificial Ventilation and Anesthesia Masks Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Artificial Ventilation and Anesthesia Masks market include:- GaleMed Corporation.
- Drägerwerk AG & Co. KGaA
- BD
- Air Liquide Medical Systems
- Koninklijke Philips N.V.
- ResMed
- Ambu A/S
- VYAIRE MEDICAL, INC.
- NIHON KOHDEN CORPORATION
- Hamilton Medical
- Thermo Fisher Scientific Inc.
- Medtronic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.33 Billion |
| Forecasted Market Value ( USD | $ 3.3 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
